Reville, Patrick K.
Kadia, Tapan
Article History
First Online: 21 April 2020
Compliance with Ethical Standards
:
: Patrick K. Reville declares that he has no conflict of interest.Tapan Kadia has received research funding from AbbVie, Pfizer, Jazz Pharmaceuticals, Genentech, and Amgen and has received compensation from AbbVie, Agios, Pfizer, Novartis, Jazz Pharmaceuticals, and Genentech for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by any of the authors.